{"organizations": [], "uuid": "9593ca5e4d5c5dc659400ba17e5e2ee6775eeb34", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180213.html", "section_title": "Archive News &amp; Video for Tuesday, 13 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-avivagen-to-seek-approval-from-tsx/brief-avivagen-to-seek-approval-from-tsx-venture-exchange-for-extension-of-warrants-idUSFWN1Q30XO", "country": "US", "domain_rank": 408, "title": "Avivagen To Seek Approval From TSX Venture Exchange For Extension Of Warrants", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-13T19:44:00.000+02:00", "replies_count": 0, "uuid": "9593ca5e4d5c5dc659400ba17e5e2ee6775eeb34"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-avivagen-to-seek-approval-from-tsx/brief-avivagen-to-seek-approval-from-tsx-venture-exchange-for-extension-of-warrants-idUSFWN1Q30XO", "ord_in_thread": 0, "title": "Avivagen To Seek Approval From TSX Venture Exchange For Extension Of Warrants", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "tsx venture exchange", "sentiment": "negative"}, {"name": "avivagen inc", "sentiment": "negative"}, {"name": "tsx", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 13 (Reuters) - Avivagen Inc:\n* AVIVAGEN TO SEEK APPROVAL FROM TSX VENTURE EXCHANGE FOR EXTENSION OF WARRANTS\n* AVIVAGEN - SEEKING APPROVAL BY TSX TO EXTEND EXPIRY DATE OF OUTSTANDING WARRANTS EXERCISABLE TO PURCHASE 1.2 MILLION COMMON SHARES AT $1.00 PER SHARE\n* AVIVAGEN INC - IF APPROVED, NEW EXPIRY DATE WILL BE OCTOBER 1, 2018\n* AVIVAGEN-‍SEEKING APPROVAL TO EXTEND EXPIRY DATE OF SECOND TRANCHE OF OUTSTANDING WARRANTS EXERCISABLE TO BUY 2.8 MILLION COMMON SHARES AT $0.90 PER SHARE ​\n* AVIVAGEN INC - ‍IF APPROVED, NEW EXPIRY DATE FOR SECOND TRANCHE OF OUTSTANDING WARRANTS EXERCISABLE TO BE OCT 1, 2018​ Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-13T19:44:00.000+02:00", "crawled": "2018-02-14T12:43:48.021+02:00", "highlightTitle": ""}